Freedom isn’t a Luxury. Freedom is a Human Right.
Access to contraception is a necessity for gender equality and the fulfillment of reproductive rights. Modern contraceptives produced in Finland give millions of women all over the world the freedom to make decisions about their own future.
Bayer’s investment of 250 million euros has culminated in a new state-of-the-art facility in Turku, from where contraceptives will be shipped to over 130 countries worldwide. The opening of the new production facility will be celebrated in September 2023. The new facility will have a crucial role in securing long-term supply of contraceptives and meeting Bayer's global sustainability goal of helping to provide 100 million women and girls in low- and middle-income countries with access to family planning.
The Finnish innovations manufactured in Supply Center Turku are the backbone of Bayer's sustainability commitment in family planning. With sustainability being in the core of Bayer’s business strategy, Finland has a unique opportunity to make an impact in women’s lives across the world.
Access to modern contraception enables women and girls to choose the number, timing and spacing of their pregnancies. This is a matter of health and a human right. It empowers women to go to school and have an education, work outside the domestic sphere, and have an active role in society. This is why Bayer is committed to providing access to contraception for 100 million women in low- and-middle income countries by 2030.
State-of-the-art facility brings vitality to Finland
The new ultramodern pharmaceutical production facility in Turku boosts the Finnish economy and the vitality of the region.
The new contraceptive production plant is a part of Bayer’s considerable investment in Finland totaling circa 250 million Euros, which also includes the modernizing of an existing facility. The total investment is among the biggest investments announced in Finland in the recent years and has a major impact on the pharmaceutical industry in Finland.
The production facility has optimized material and personnel flows and uses the latest digital technologies such as digital visual management to improve efficiency. The state-of-the-art facilities give an edge in global competition and excellent conditions to meet the tight compliance regulations of the medical sector.
Most importantly, the operations in the new facility and Bayer Finland as a whole are climate neutral.